·AIM:To evaluate the effects of hexuemingmu tablets for retinal hemorrhage caused by retinal vein occlusion.·METHODS:A randomized controlled study was performed on 72 patients(72 eyes).Patients were divided into 2 groups randomly:38 patients in I group(hexuemingmu,38 eyes);34 patients in Ⅱgroup(fufangxueshuantong,34 eyes).The standard of effectiveness:Cure:best-corrected visual acuity(BCVA)recovered to the statements before the hemorrhage the case recorded or the level patients expressed,retinal hemorrhage,edema completely absorbed;Markedly:BCVA improved more than three rows compared to the one the case recorded when registered.Effective:BCVA only improved more than one row;Invalid:BCVA is not improved or gets worse.·RESULTS:After six months,BCVA of 68 eyes was improved,the total effective rate was 94%,marked improvement rate was 31%(22 eyes).Cure rate was 10%(7 eyes).In I group:the total effective rate was 97%(37 eyes),marked improvement rate was 39%(15 eyes).Cure rate was 13%(5 eyes).In Ⅱ group:the total effective rate was 91%(31 eyes),marked improvement rate was 21%(7 eyes),cure rate was 7%(2 eyes),the rate of effectiveness of two groups didn’t show statistical difference(P=0.341),while the rate of marked improvement of two groups showed statistical difference(P<0.05)。·CONCLUSION:Hexuemingmu tablets is an effective drug for retinal hemorrhage caused by retinal vein occlusion.It’s helpful in eliminating the hemorrhage and improving the patient’s BCVA.·